We identify a specific role for AHR in regulating the TGFβ-SMAD3 signalling axis in CPCs from these tumours and identify a new role for TGFβ-SMAD3 activity in medulloblastoma CPC differentiation. This evidence concerns the gene SMAD3 and neoplasm.